sj-pdf-1-taw-10.1177_2042098621989134 – Supplemental material for Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews

Pelletier, Ryan; Ng, Kelvin; Alkabbani, Wajd; Labib, Youssef; Mourad, Nicolas; Gamble, John-Michael

doi:10.25384/SAGE.13653382.v1

sj-pdf-1-taw-10.1177_2042098621989134.pdf (475.82 kB)

sj-pdf-1-taw-10.1177_2042098621989134 – Supplemental material for Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews

journal contribution

posted on 2021-01-28, 01:06 authored by Ryan Pelletier, Kelvin Ng, Wajd Alkabbani, Youssef Labib, Nicolas Mourad, John-Michael Gamble

Supplemental material, sj-pdf-1-taw-10.1177_2042098621989134 for Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews by Ryan Pelletier, Kelvin Ng, Wajd Alkabbani, Youssef Labib, Nicolas Mourad and John-Michael Gamble in Therapeutic Advances in Drug Safety